Thrombosis risk factors in MPNs
Thrombosis is a major risk factor for mortality and morbidity in patients with myeloproliferative neoplasms (MPNs). Thus, it is crucial that the risk factors for this complication are understood and controlled effectively. In this interview, Tiziano Barbui, MD, from Hospital Papa Giovanni XXIII, Bergamo, Italy, discusses the patient-related and disease-related risk factors, highlighting those which are modifiable. Prof. Barbui emphasizes the need for careful aspirin use, with platelet level monitoring to direct the dosage used. This video was recorded at the Myeloproliferative Neoplasms Advances Day 2017 in London, UK.
